Combining Aspirin With Cilostazol or Clopidogrel in Large-vessel Minor Stroke or TIA

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 870 participants.

Also called NCT06591351

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 870 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06591351
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Egypt (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06591351. Randomized; double masking; primary purpose treatment. Start 2022-05-01 (actual); primary completion 2024-09-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Combining Aspirin With Cilostazol or Clopidogrel in Large-vessel Minor Stroke or TIA
Intervention (Drug)
Cilostazol 100 MG
Intervention (Drug)
Clopidogrel
Lead sponsor
Kafrelsheikh University (class: other)

Record details

Record id
cardio:ct-nct06591351
Content hash
af58dfaeb0ef99a4f1dc075b813f2025e28a3256d489cd3dfc01977232cdf88d